The Effect of Montelukast and Low-Dose Theophylline on Cardiovascular Disease Risk Factors in Asthmatics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Effect of Montelukast and Low-Dose Theophylline on Cardiovascular Disease Risk Factors in Asthmatics

Published:2007-09 Issue:3 Volume:132 Page:868-874
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Allayee Hooman,Hartiala Jaana,Lee Won,Mehrabian Margarete,Irvin Charles G.,Conti David V.,Lima John J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference27 articles.

1. Asthma, body mass index, and C-reactive protein among US adults;Ford;J Asthma,2003

2. Chlamydia pneumoniaeinfection and inflammation in adults with asthma;Savykoski;Respiration,2004

3. High sensitivity C-reactive protein in asthma;Takemura;Eur Respir J,2006

4. Are patients with asthma at increased risk of coronary heart disease?;Iribarren;Int J Epidemiol,2004

5. Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study;Hozawa;Chest,2006

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Montelukast, an available and safe anti-asthmatic drug, prevents maladaptive remodelling and maintains cardiac functionality following myocardial infarction;Scientific Reports;2024-02-09

2. Asthma aggravates alzheimer's disease by up-regulating NF- κB signaling pathway through LTD4;Brain Research;2024-02

3. Theophylline for the management of respiratory disorders in adults in the 21st century: A scoping review from the American College of Clinical Pharmacy Pulmonary Practice and Research Network;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-07-19

4. Evaluating the effect of montelukast tablets on respiratory complications in patients following blunt chest wall trauma: A double-blind, randomized clinical trial;Chinese Journal of Traumatology;2023-03

5. The Hidden Pandemic of COVID-19-Induced Organizing Pneumonia;Pharmaceuticals;2022-12-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3